Paclitaxel-Induced Resistant Tumor Models
Despite the excellent clinical response to paclitaxel therapy, drug resistance inevitably develops in subsequent treatments. The mechanisms for resistance to...
Continue Reading
Despite the excellent clinical response to paclitaxel therapy, drug resistance inevitably develops in subsequent treatments. The mechanisms for resistance to...
Continue Reading
Radiopharmaceuticals have proven to be effective agents since they can be successfully applied for both diagnostics and therapy. Radionuclide drug...
Continue Reading
An inevitable challenge emerges over time as tumors develop drug resistance, resulting in treatment failure. This resistance is inherent to...
Continue Reading
Join WuXi AppTec at IMMUNOLOGY2024™. For this year’s annual meeting of the American Association of Immunologists (AAI), WuXi Biology has...
Continue Reading
What if a constructed PROTAC with a confirmed high-affinity warhead doesn’t work as expected? That means we need to take...
Continue Reading
In the last decade, targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific...
Continue Reading
Drug Discovery Chemistry Conference 2023 WuXi AppTec has developed technologies to facilitate RNA small molecule screening, an exciting frontier in...
Continue Reading
Drug Discovery Chemistry Conference Powerful biophysical and structural biology tools enable the study of large numbers of covalent fragments and...
Continue Reading
Drug Discovery Chemistry Conference 2023 DNA-Encoded library (DEL) screening is now commonly used in the pharmaceutical industry to find novel...
Continue Reading